Clinical Trial

Respiratory Muscle Strength and Aerobic Capacity in Scleroderma

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 15, 2024 (before its estimated October 20, 2024 completion). Its status may not reflect the trial's current state.
Summary
Primary aim of this study was to compare respiratory muscle strength, aerobic capacity, dyspnea, pulmonary function tests and fatigue values with healthy controls. The secondary aim was to evaluate the relationship between respiratory muscle strength and other parameters in these patients and to examine the factors that may affect respiratory muscle strength. Respiratory muscle strength, aerobic capacity, respiratory function tests and fatigue will be evaluated
Trial Details
NCT Number NCT06554132
Lead Sponsor Firat University
Conditions Scleroderma
Enrollment 15 participants
Start Date 2024-08-20
Primary Completion 2024-10-20 (estimated)
Study Completion 2024-10-30 (estimated)
Updated on ClinicalTrials.gov 2024-08-15